The roundup is formatted with the title of the story, followed by the news source in parentheses and a brief summary. If you find a particularly interesting article, please send it to firstname.lastname@example.org for inclusion in next week’s roundup.
Chris Pickett, former policy analyst for the American Society of Biochemistry and Molecular Biology, takes on new role as director of Rescuing Biomedical Research. A farewell to the ASBMB (ASBMB Policy Blotter)
The U.S. Senate Health, Education, Labor and Pensions committee will not introduce companion legislation to the U.S. House’s 21st Century Cures. Instead, the HELP committee will vote on smaller biomedical research bills that have bipartisan support. Peter Sullivan reports for The Hill saying: “Democrats say they will block passage of any bill that does not include new mandatory funding for the NIH, meaning it would be guaranteed and not subject to the annual appropriations process.”
To read more:
Senators continue partisan feud over NIH funding (Modern Healthcare)
Dems threaten to block health bills over NIH funding (Washington Examiner)
NIH fight threatens medical reforms (The Hill)
The American Statistical Association issued an unprecedented policy statement for scientists on how to appropriately utilize the P-value statistical tool.
To read more:
How to Use P-Values Correctly (The Scientist)
Heidi Ledford reports for Nature on the U.S. Patent and Trademark Office investigation into the dispute over patent ownership of the gene-editing tool CRISPR-Cas9.
Former U.S. Reps. Tim Penny, D-Minn., and Jim Kolbe, R-Ariz., write in an op-ed for the Washington Examiner that U.S. President Barack Obama’s ‘Cancer Moonshot’ could be funded by modernizing the one-dollar currency. They write: “By taking the step to modernize our one-dollar currency, which the Government Accountability Office (GAO) has recommended ten times and nearly every other major economy in the world has already done, we could pay the initial “Moonshot” investment 13 times over.” Dollar coin: Change that could help us achieve a “Moonshot” (Washington Examiner)